OBJECTIVES Medical devices, together with pharmacotherapy are supportive treatment of many acute and chronic diseases. The place of their dispensing and direct sale is the dispenser of medical devices. Many medical devices are reimbursed from public health insurance funds entirely, for others, particularly advanced functional types of medical devices, there must the patient  participate on the price or he can buy them according own decision. METHODS The target of the work was to analyse the data from paid databases of Slovak authority National Center for Health Information that collects the outputs of provided health care services. The most recent data were from 1.1. - 30.9. 2014. RESULTS Referring to the Center for Health Information until 30.9.2013 there were 226 registered establishments that sell medical devices. Their specialization were dispenser of medical devices (n=163), dispenser of orthopedic devices (n=48) and dispenser of audioprotetic devices (n=15). Expenditure of reimbursed medical devices from public health insurance funds amounted n-_{monthly packaging}=8,8mil and n-_{monthly value}=12,7 mil €. The highest shares had the group medical devices for incontinence and urinary retention (n-_packages=7,7 mil, n-_packages%=86.9, n-_values=3,9 mil €, n-_value%=30.9), the group plasters and bandaging materials  (n-_packages=0,5 mil, n-_packages%=6.1, n-_values=2,6mil €, n-_value%=10.2) and medical devices for ostomates (n-_packages=0,4 mil, n-_packages%=4.6, n-_values=1,6 mil €, n-_value%=8.1).  Direct sale of medical devices to the patients reached n-_{monthly packaging}=0,9 mil and n-_{monthly value}=1,1mil €. The highest shares had the group medical devices for incontinence and urinary retention (n-_packages=5,7 mil, n-_packages%=50.3, n-_values=2,6 mil €, n-_value%=26.2), the group plasters and bandaging materials (n-_packages=3,5 mil, n-_packages%=30.9, n-_values=2,0 mil €, n-_value%=20.4) and medical devices for diabetics (n-_packages=0,5 mil, n-_packages%=4.5, n-_values=0,7 mil €, n-_value%= 7.3). CONCLUSIONS Medical devices are reimbursed from public health insurance funds or paid by patient and their proportion constitutes 7:1 in packages and 11:1 in Eur.